These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 29565467)
1. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells. Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467 [TBL] [Abstract][Full Text] [Related]
2. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585 [TBL] [Abstract][Full Text] [Related]
3. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway. Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248 [TBL] [Abstract][Full Text] [Related]
4. Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells. Lu Y; Wang B; Shi Q; Wang X; Wang D; Zhu L Sci Rep; 2016 Dec; 6():39123. PubMed ID: 27982118 [TBL] [Abstract][Full Text] [Related]
5. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992 [TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway. Wang L; Yu Z; Ren S; Song J; Wang J; Du G Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603 [TBL] [Abstract][Full Text] [Related]
7. BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells. Li FS; Huang J; Cui MZ; Zeng JR; Li PP; Li L; Deng Y; Hu Y; He BC; Shu DZ Oncol Rep; 2020 Feb; 43(2):415-426. PubMed ID: 31894286 [TBL] [Abstract][Full Text] [Related]
8. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer. Ma Y; Yu C; Mohamed EM; Shao H; Wang L; Sundaresan G; Zweit J; Idowu M; Fang X Oncogene; 2016 Nov; 35(47):6132-6142. PubMed ID: 27132509 [TBL] [Abstract][Full Text] [Related]
9. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244 [TBL] [Abstract][Full Text] [Related]
10. Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer. Kim H; Ju JH; Son S; Shin I FEBS Lett; 2020 Mar; 594(6):1021-1035. PubMed ID: 31736063 [TBL] [Abstract][Full Text] [Related]
11. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway. Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361 [TBL] [Abstract][Full Text] [Related]
12. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism. Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081 [TBL] [Abstract][Full Text] [Related]
13. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth. Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777 [TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism. Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918 [TBL] [Abstract][Full Text] [Related]
15. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia. Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232 [TBL] [Abstract][Full Text] [Related]
16. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway. Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer. Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394 [TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer. Wu J; Chai H; Xu X; Yu J; Gu Y Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation. Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993 [TBL] [Abstract][Full Text] [Related]
20. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer. Kim SL; Park YR; Lee ST; Kim SW Int J Oncol; 2017 Dec; 51(6):1809-1820. PubMed ID: 29075793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]